There are many problems with the plan. It ignores the fact, for instance, that generic drugs, which make up 90% of ...

Buried in a technical document released by the Centers for Medicare and Medicaid Services is a convoluted paragraph that may ...

Merck plans to spend $895 million to expand a De Soto, Kansas, manufacturing facility for its animal health segment, the ...

Britain's GSK and drug developer iTeos Therapeutics said on Tuesday they have stopped developing an experimental lung cancer ...

Bristol Myers Squibb (BMY) and MPLX present compelling value picks, offering high-income potential and attractive valuations ...

The order calls on the health department, led by Robert F. Kennedy Jr., to broker new price tags for drugs over the next ...

A number of US pharmaceutical groups have recently made announcements about expanding domestic manufacturing. These include ...

Cyber attacks on companies are no longer a rarity. Volker Buß, CISO at the Merck Group, explains in the CSO interview what is ...

GSK has stopped development of anti-TIGIT antibody belrestotug. | GSK has stopped development of anti-TIGIT antibody ...

EARNINGS FORECAST: Merck's earnings before interest, taxes, depreciation, amortization and one-off items is forecast to come in at 1.51 billion euros, according to the consensus. The company reported ...

HELSINKI, May 13, 2025 (GLOBE NEWSWIRE) -- TILT Biotherapeutics (Tiltbio), a clinical-stage biotechnology company developing ...